Postoperative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas
✍ Scribed by Tomasz Trojanowski; Jerzy Pceszyński; Krzysztof Turowski; Stanisław Kamiński; Igor Gościński; Marian Reinfus; Tadeusz Krzyszkowski; Marek Pyrich; Adam Bielawski; Czesława Leszczyk; Barbara Bendarzewska; Andrzej Staszczak; Halina Koźniewska
- Publisher
- Springer US
- Year
- 1988
- Tongue
- English
- Weight
- 464 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0167-594X
No coin nor oath required. For personal study only.
✦ Synopsis
A prospective, randomized trial evaluates the effects of two postoperative treatment regimens on survival in 198 adult patients with supratentorial gliomas. All patients were irradiated with 6 000 rads after possibly radical removal of tumors. CCNU administration in the dosis of 100 mg/sq m of body surface every 6-8 weeks following surgery proved to have no significant effect on the survival of patients. The median survival time in patients receiving radiation therapy alone was 61 _+ 7 weeks, while in those receiving additional chemotherapy was 56 + 4 weeks. Tumor histological malignancy and patients age were found to be the only important prognostic factors, irrespective of the treatment modality.
📜 SIMILAR VOLUMES
## Background: Although the standard therapy for locally advanced hypopharyngeal cancer remains surgery and postoperative radiotherapy (rt), alternative treatment approaches include induction chemotherapy and rt. the purpose of this retrospective study was to compare the long-term outcome of these
Mice bearing transplanted glioma received 0.9% NaCl, 0.1 mg of BLM, or 200-250 pCi of "'In-BLM (0.1 mg BLM) daily for 5 days intraperitoneally. After therapy, tumor sizes were in the order NaCl > BLM > "'In-BLM. On the 11th day after the first injection, tumor size (m3) in the "'In-BLM group was 1,2